C102H100Br3ClF9N17O15 — CID 162015079
4-[3-amino-6-[(1S,3R)-4,4-difluoro-3-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[(1S,3S,4S)-3-hydroxy-4-methoxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[4-(hydroxymethyl)piperidine-1-carbonyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[2-amino-5-(morpholine-4-carbonyl)-3-pyridinyl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide (PubChem CID 162015079) has the molecular formula C102H100Br3ClF9N17O15 and a molecular weight of 2250.17 g/mol. Its IUPAC name is 4-[3-amino-6-[(1S,3R)-4,4-difluoro-3-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[(1S,3S,4S)-3-hydroxy-4-methoxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[4-(hydroxymethyl)piperidine-1-carbonyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[2-amino-5-(morpholine-4-carbonyl)-3-pyridinyl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide.
| Compound Name | 4-[3-amino-6-[(1S,3R)-4,4-difluoro-3-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[(1S,3S,4S)-3-hydroxy-4-methoxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[4-(hydroxymethyl)piperidine-1-carbonyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[2-amino-5-(morpholine-4-carbonyl)-3-pyridinyl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide |
|---|---|
| PubChem CID | 162015079 |
| Molecular Formula | C102H100Br3ClF9N17O15 |
| Molecular Weight | 2250.17 g/mol |
| Exact Mass | 2245.47 |
| IUPAC Name | 4-[3-amino-6-[(1S,3R)-4,4-difluoro-3-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[(1S,3S,4S)-3-hydroxy-4-methoxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[3-amino-6-[4-(hydroxymethyl)piperidine-1-carbonyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide;4-[2-amino-5-(morpholine-4-carbonyl)-3-pyridinyl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-hydroxyethyl]-2-fluorobenzamide |
| SMILES | CO[C@H]1CC[C@H](c2cnc(N)c(-c3ccc(C(=O)N[C@H](CO)c4cc(F)cc(Br)c4)c(F)c3)n2)C[C@@H]1O.Nc1ncc(C(=O)N2CCC(CO)CC2)nc1-c1ccc(C(=O)N[C@H](CO)c2cc(F)cc(Br)c2)c(F)c1.Nc1ncc(C(=O)N2CCOCC2)cc1-c1ccc(C(=O)N[C@H](CO)c2cc(F)cc(Br)c2)c(F)c1.Nc1ncc([C@H]2CCC(F)(F)[C@H](O)C2)nc1-c1ccc(C(=O)N[C@H](CO)c2cccc(Cl)c2)c(F)c1 |
| InChI | InChI=1S/C26H26BrF2N5O4.C26H27BrF2N4O4.C25H23BrF2N4O4.C25H24ClF3N4O3/c27-17-7-16(8-18(28)10-17)22(13-36)33-25(37)19-2-1-15(9-20(19)29)23-24(30)31-11-21(32-23)26(38)34-5-3-14(12-35)4-6-34;1-37-23-5-3-13(9-22(23)35)20-11-31-25(30)24(32-20)14-2-4-18(19(29)8-14)26(36)33-21(12-34)15-6-16(27)10-17(28)7-15;26-17-7-15(8-18(27)11-17)22(13-33)31-24(34)19-2-1-14(10-21(19)28)20-9-16(12-30-23(20)29)25(35)32-3-5-36-6-4-32;26-16-3-1-2-13(8-16)20(12-34)33-24(36)17-5-4-15(9-18(17)27)22-23(30)31-11-19(32-22)14-6-7-25(28,29)21(35)10-14/h1-2,7-11,14,22,35-36H,3-6,12-13H2,(H2,30,31)(H,33,37);2,4,6-8,10-11,13,21-23,34-35H,3,5,9,12H2,1H3,(H2,30,31)(H,33,36);1-2,7-12,22,33H,3-6,13H2,(H2,29,30)(H,31,34);1-5,8-9,11,14,20-21,34-35H,6-7,10,12H2,(H2,30,31)(H,33,36)/t22-;13-,21+,22-,23-;22-;14-,20+,21+/m1010/s1 |
| InChIKey | YTZOCWMYVRJSCD-DMAYJEJESA-N |
| XLogP | 14.50 |
| TPSA | 511.40 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 147 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2250.17 |
| LogP ≤ 5 | 14.50 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 26 |